Chirfi Guindo - Jul 1, 2022 Form 3/A - restatement Insider Report for Merck & Co., Inc. (MRK)

Role
Chief Marketing Officer
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Chirfi Guindo
Stock symbol
MRK
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
3/A - RESTATEMENT
Date filed
4/28/2023, 04:18 PM
Date Of Original Report
Jul 8, 2022
Previous filing
Feb 23, 2022
Next filing
Aug 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 1.4K Jul 1, 2022 Direct F1, F2
holding MRK Common Stock-401(k) Plan 50.8 Jul 1, 2022 By 401(k)

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to amend the Form 3, filed on 07/08/2022 on behalf of the Reporting Person, solely to restate the number of shares beneficially owned (direct) under Column 2 of Table I.
F2 Holdings include shares acquired in dividend reinvestment transactions.

Remarks:

Power of Attorney has been previously filed.